CD8A and neoplasm: Another study by Bian et al. demonstrated that tumor cells could hijack methionine metabolism from CD8+ T cells for their own benefit, thereby impairing T cell survival and function by reducing H3K79me2 levels and inhibiting STAT5 signaling in CD8+ T cells [9].